Latest Biotech News

A multicenter randomized phase II trial published in BMC Cancer revealed that nab-paclitaxel combined with cisplatin outperforms gemcitabine plus cisplatin as chemotherapy in patients with...

Made Scientific celebrated the opening of a new 60,000-square-foot GMP-compliant manufacturing facility and headquarters in Princeton, New Jersey, enhancing its capabilities in cell therapy...

Finnish biotech Genomill Health introduced Bridge Capture, a novel targeted next-generation sequencing sample preparation technique enabling simple, cost-effective, and automatable detection of...

Massachusetts Institute of Technology researchers employed artificial intelligence to revolutionize the design of lipid nanoparticles (LNPs), crucial delivery vehicles for RNA vaccines and...

Recent scientific investigations have expanded the understanding of platelets, traditionally known for their role in blood clotting, revealing unexpected functions in DNA damage surveillance and...

A recent study published in BMC Cancer explores the psychological aftermath of cancer survivorship among adolescents and young adults (AYAs), highlighting loneliness as a significant contributor...

The U.S. FDA has granted full and expedited approval to Precigen Inc.’s gene therapy, Papzimeos (zopapogene imadenovec), targeting recurrent respiratory papillomatosis (RRP), a rare disease marked...

Pfizer’s sickle cell disease candidate, inclacumab, failed to meet primary endpoints in a pivotal Phase 3 clinical trial, signaling a setback for the company's portfolio in hematology. This...

Researchers at MIT and collaborators have pioneered the application of generative artificial intelligence to design novel antibiotic molecules capable of targeting drug-resistant pathogens such as...

Scientists from the Institute for Bioengineering of Catalonia and Dexeus University Hospital have, for the first time ever, recorded human embryo implantation in real time and three-dimensional...

New clinical trials and studies reveal advancements in cancer immunotherapy across multiple tumor types. A Phase II trial showed the combination of nab-paclitaxel and cisplatin outperforming...

Promising advancements emerged in neonatal and pediatric healthcare. Airway Therapeutics announced an expanded multinational Phase III trial for zelpultide alfa, targeting bronchopulmonary...

Recent innovations in materials science demonstrate significant potential for energy and manufacturing sectors. Researchers unveiled one-dimensional titanate nanotubes designed to enhance...

Notable regulatory and funding developments shape the biotech landscape. The reinstatement of the U.S. childhood vaccine safety task force aims to enhance vaccine monitoring amid controversial...

Cutting-edge research deepens understanding of immune mechanisms and cellular dynamics. Studies reveal that genetically engineered regulatory T cells with chimeric antigen receptors can...

Innovations in diagnostic technologies enhance precision medicine and research capabilities. Bionano Genomics reported advancements in optical genome mapping software with AI-driven variant...

The FDA has granted full and expedited approval to Precigen Inc.'s gene therapy, Papzimeos (zopapogene imadenovec), targeting adults with recurrent respiratory papillomatosis (RRP), a rare chronic...

Pfizer announced the failure of its sickle cell drug candidate, inclacumab, in a pivotal Phase III clinical trial, where it did not demonstrate significant reduction in vaso-occlusive crises...

Rockefeller University researchers have reported encouraging clinical outcomes from a Phase I trial of 2141.V11, an Fc-optimized CD40 agonistic antibody administered intratumorally to metastatic...

Researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital have captured, for the first time, high-resolution three-dimensional videos of human embryo...